News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Kieffer Tara Lynn
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/05/2022 |
4
| Kieffer Tara Lynn (Sr. VP, New Product Dev.) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 498 shares
@ $44.33, valued at
$22.1k
|
|
| 11/28/2022 |
4
| Kieffer Tara Lynn (Sr. VP, New Product Dev.) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 18,500 shares
@ $0
Granted 40,000 options to buy
@ $45, valued at
$1.8M
|
|
| 02/15/2022 |
4
| Kieffer Tara Lynn (Sr. VP, New Product Dev.) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 327 shares
@ $0
Granted 1,289 shares
@ $0
Paid exercise price by delivering 552 shares
@ $62.49, valued at
$34.5k
|
|
| 11/23/2021 |
4
| Kieffer Tara Lynn (Sr. VP, New Product Dev.) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 6,800 shares
@ $0
Granted 28,400 options to buy
@ $75.33, valued at
$2.1M
|
|
| 12/08/2020 |
4
| Kieffer Tara Lynn (Sr. VP, New Product Dev.) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 65,000 options to buy
@ $42.62, valued at
$2.8M
|
|
|
|